Carthera
PrivateLast Round
Series B
Extension
Dec 11, 2023
Total Funding Raised
$102.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Carthera is a medtech company that develops ultrasound-based medical devices designed to treat brain disorders through intracranial implants and microbubble agents that enhance drug delivery to the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carthera Comparables
Compare Carthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OxSonics Therapeutics | 79% | |
| TheraSonic | 78% | |
| NaviFUS Corp. | 77% |
Carthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 11, 2023 | ||||
| Series B | Jun 27, 2023 | ||||
| Grant | Sep 14, 2020 | ||||
| Series B | Dec 12, 2018 | ||||
| Grant | Oct 1, 2016 | ||||
Series A | Jul 8, 2015 |
Key People
Founding team and executive leadership
Carthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series B |
| Unorthodox Ventures | Series B, Series B Extension |
| Supernova Invest | Series B, Seed, Series B Extension |
| Panakès Partners | Series B, Series A |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 226% MoM, reaching 2.9K.
- Jun 27, 2023
$40M round led by European Innovation Council and Relyens.
Carthera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Carthera's valuation, stock price, and market status.
Is Carthera a public or private company?
Carthera is a private company.
What is the current stock price of Carthera?
Carthera is a private company with no public stock price. No recent secondary market data is available.
How much is Carthera worth (valuation)?
Valuation information for Carthera is not publicly available.
Can I buy Carthera stock?
Carthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Carthera's last funding round?
Carthera's most recent funding round was Series B Extension on December 11, 2023.
Who are the main investors in Carthera?
Key investors in Carthera include European Innovation Council, Unorthodox Ventures, Panakès Partners.
Will Carthera IPO soon?
No public IPO plans have been announced for Carthera.
How can I track Carthera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carthera's secondary market activity and sign up for updates.